Author:
Keenan Robert T.,Schlesinger Naomi
Publisher
Springer Science and Business Media LLC
Reference45 articles.
1. http://store.globaldata.com/market-reports/pharmaceuticals-and-healthcare/opportunityanalyzer-gout-opportunity-analysis-and-forecast-to-2018#.Vso-ZVJflfQ . Accessed 2/21/16.
2. Martinon F, Petrilli V, Mayor A, Tardivel A, Tschopp J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature. 2006;440(7081):237–41. This study demonstrates the effect of monosodium urate crystals on the NALP3 inflammasome.
3. So A, De Smedt T, Revaz S, Tschopp J. A pilot study of IL-1 inhibition by anakinra in acute gout. Arthritis Res Ther. 2007;9(2):R28.
4. Chen K, Fields T, Mancuso CA, Bass AR, Vasanth L. Anakinra’s efficacy is variable in refractory gout: report of ten cases. Semin Arthritis Rheum. 2010;40(3):210–4.
5. Ottaviani S, Molto A, Ea HK, Neveu S, Gill G, Brunier L, et al. Efficacy of anakinra in gouty arthritis: a retrospective study of 40 cases. Arthritis Res Ther. 2013;15(5):R123.
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献